Header Logo

Connection

NABIL AHMED to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications NABIL AHMED has written about Clinical Trials, Phase I as Topic.
NABIL AHMED
Connection Strength
0.144
Clinical Trials, Phase I as Topic
  1. Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma. Nat Commun. 2020 07 15; 11(1):3549.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.